The role of sleep problems in central pain processing in rheumatoid arthritis
- PMID: 23124650
- PMCID: PMC3535519
- DOI: 10.1002/art.37733
The role of sleep problems in central pain processing in rheumatoid arthritis
Abstract
Objective: Among rheumatoid arthritis (RA) patients, the intensity of pain may be out of proportion to the severity of peripheral inflammation. This observation suggests that mechanisms of central nervous system pain amplification, such as diminished conditioned pain modulation (CPM), may play a role in enhancing pain perception among some RA patients. This study was undertaken to examine the level of CPM, pressure-pain threshold, and pressure-pain tolerance among RA patients compared to healthy controls.
Methods: Fifty-eight female RA patients and 54 age-matched female control subjects without chronic pain underwent quantitative sensory testing (QST) to assess CPM levels, pressure-pain thresholds, and pressure-pain tolerance levels. CPM was induced using a cold water bath, and the pain threshold (when patients first felt pain) and pain tolerance (when pain was too much to bear) were assessed with an algometer. Associations between RA and each QST outcome were analyzed using linear regression. Sleep problems, mental health, and inflammation were assessed as mediators of the relationship between RA and QST outcomes.
Results: The median CPM level was 0.5 kg/cm2 (interquartile range [IQR] -0.1, 1.6) among RA patients, compared to a median of 1.5 kg/cm2 (IQR -0.1, 2.5) among controls (P=0.04). RA patients, compared to controls, had a lower pain threshold and lower pain tolerance at the wrists (each P≤0.05). In addition, RA patients had greater problems with sleep, pain catastrophizing, depression, and anxiety (P<0.0001 versus controls). Results of mediation analyses suggested that low CPM levels might be attributed, in part, to sleep disturbance (P=0.04).
Conclusion: RA patients have impaired CPM when compared to pain-free control subjects. Sleep problems may mediate the association between RA and attenuated CPM.
Copyright © 2013 by the American College of Rheumatology.
Figures


References
-
- Gerecz-Simon EM, Tunks ER, Heale JA, Kean WF, Buchanan WW. Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. Clin Rheumatol. 1989;8(4):467–474. - PubMed
-
- Leffler AS, Kosek E, Lerndal T, Nordmark B, Hansson P. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. European Journal of Pain: Ejp. 2002;6(2):161–176. - PubMed
Publication types
MeSH terms
Grants and funding
- R21 AR057920/AR/NIAMS NIH HHS/United States
- AR-055989/AR/NIAMS NIH HHS/United States
- K24 AR052403/AR/NIAMS NIH HHS/United States
- AR-057920/AR/NIAMS NIH HHS/United States
- AR-052403/AR/NIAMS NIH HHS/United States
- AG-034982/AG/NIA NIH HHS/United States
- K24 AR055989/AR/NIAMS NIH HHS/United States
- R01 AR049880/AR/NIAMS NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- AR-49880/AR/NIAMS NIH HHS/United States
- AR-047782/AR/NIAMS NIH HHS/United States
- AR-057578/AR/NIAMS NIH HHS/United States
- K23 AR057578/AR/NIAMS NIH HHS/United States
- P60 AR047782/AR/NIAMS NIH HHS/United States
- R01 AG034982/AG/NIA NIH HHS/United States
- UL1-RR-025758/RR/NCRR NIH HHS/United States
- R01 AR061362/AR/NIAMS NIH HHS/United States